Fingerprint
Dive into the research topics of 'Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma
Ghassan K. Abou-Alfa, Robert Mayer, Alan P. Venook, Allison F. O'Neill, Muhammad S. Beg, Michael LaQuaglia, Peter T. Kingham, Rachel Kobos, Olca Basturk, Cameron Brennan, Adam Yopp, James J. Harding, Stephen Leong, John Crown, Emir Hoti, Gregory Leonard, Michele Ly, Mikaela Bradley, Emily Valentino, David Markowitz
Research output: Contribution to journal › Article › peer-review
24
Scopus
citations